Health Strategies Group Key Finding #1 5/10/2018 Health Strategies Group Author/Artist Predictive Analysis Reveals Attributes Driving Access Decisions Vary by Stakeholder and Cancer Type Health Strategies Group’s predictive analysis model reveals that attributes driving access decisions vary by stakeholder and hematologic cancer type. The ability to extend survival and reduce adverse-events drives access decisions for many health plans across hematologic cancer types. However, cost pressures drives increased influence of therapy costs among CML and CLL cancer types. Ability to extend survival is largest determinant of access within oncology groups across CML, multiple myeloma, and CLL treatments. To request slides info@healthstrategies.com